News

February 3, 2020February 3, 2020

ATS Foundation, FSR Award Sarcoidosis Research Grant to Nicholas Arger of UCSF for Immune Cell Study

News

The American Thoracic Society (ATS) Foundation Research Program and the Foundation for Sarcoidosis Research (FSR) have awarded a Foundation Partner Grant to Nicholas Arger, MD, at the University of ... Read more

January 27, 2020January 27, 2020

aTyr and Kyorin Partner to Bring Potential Lung Sarcoidosis Treatment, ATYR1923, to Japan

News

aTyr Pharma announced a collaboration and license agreement with Kyorin Pharmaceutical to develop and commercialize ATYR1923, its potential disease-modifying treatment for those with interstitial lung diseases (ILDs), including pulmonary sarcoidosis, ... Read more

January 20, 2020January 20, 2020

Stanford Program Reaches Milestone With 1,000th Transplant Performed on Woman with Sarcoidosis

News

The transplantation program at Stanford Medicine has hit a milestone with its 1,000th procedure — performed on a 54-year-old woman with sarcoidosis. The surgery, carried under the Heart-Lung & ... Read more

January 6, 2020January 6, 2020

Testicular Sarcoidosis Can Be Cause of Infertility, Case Report Finds

News

While sarcoidosis affecting the testicles is rare, it can be a cause of infertility in men, according to a new case report. The report, “Sarcoidosis is a rare cause ... Read more

December 17, 2019December 17, 2019

ATYR1923 Is Safe, Well-tolerated by Pulmonary Sarcoidosis Patients, Phase 1/2 Trial Shows

News

ATYR1923, aTyr Pharma’s lead investigational therapy for pulmonary sarcoidosis, is safe and well-tolerated, according to interim data from a Phase 1b/2a clinical trial. ATYR1923 is a first-in-class disease-modifying therapy in ... Read more

December 9, 2019December 9, 2019

Subgroup of Active T-cells Linked to Worse Disease in Sarcoidosis, Study Reports

News

The lungs of patients with sarcoidosis are burdened with a more active subset of immune T-cells, called mucosal-associated invariant T (MAIT) cells, a study reports. The activity of these ... Read more

December 6, 2019December 6, 2019

HHS Secretary Alex Azar Touts White House Efforts to Cure Rare Diseases

News

Despite skyrocketing healthcare costs, President Trump is committed to protecting the 30 million or so Americans with rare diseases and ensuring timely, affordable access to lifesaving treatments, the nation’s ... Read more

December 2, 2019December 2, 2019

Certain Immune Cells May Drive Sarcoidosis by Producing Inflammatory Agents, Study Suggests

News

Intermediate monocytes, a type of immune cell, may contribute to the development and progression of sarcoidosis through the production of TARC — a molecule that attracts other specific immune ... Read more

November 25, 2019November 25, 2019

Acthar Gel May Improve Sarcoidosis Symptoms, Real-world Study Shows

News

Acthar Gel (repository corticotropin injection, or RCI) can improve sarcoidosis symptoms, a real-world study shows. Titled “Repository corticotropin injection in patients with advanced symptomatic sarcoidosis: retrospective analysis of medical ... Read more

November 18, 2019November 18, 2019

UCLA Launches Fundraising Effort for New Research Center for Sarcoidosis, Other Advanced Lung Diseases

News

The University of California, Los Angeles (UCLA) is launching a fundraising initiative to help improve treatment for advanced lung diseases, including sarcoidosis. The fundraising effort — called the Lung ... Read more

Pin It on Pinterest